{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:34:14Z","timestamp":1787747654016,"version":"build-2784847793"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The development of endocrine resistance is a major clinical problem in estrogen receptor-positive (ER<jats:sup>+<\/jats:sup>) breast cancer (BrCa) treatment, in which how cancer cells acquire resistance remains obscure. Hyaluronan synthase 2 (HAS2) is the most critical synthase in producing hyaluronan and is well known for its involvement in cancer growth, metabolism and metastasis. Recent evidence has proved that HAS2 is involved in cellular acquired resistance to drug therapy in BrCa. In this work, we first observed that HAS2 expression was decreased in the endocrine-resistant ER<jats:sup>+<\/jats:sup> BrCa cells. Further knocking-out experiments confirmed that the loss of HAS2 in parental ER<jats:sup>+<\/jats:sup> BrCa cells resulted in a following antiestrogen resistance. Next, we found that the HAS2-loss could induce an upregulation of Ezrin, a member of the membrane cytoskeletal protein family who plays key roles in cellular signal transduction. Notably, we identified that the increase of Ezrin induced by HAS2-loss could inhibit the ER\u03b1 expression and augment antiestrogen resistance, suggesting that a HAS2-Ezrin-ER axis may be associated with the acquirement of endocrine resistance in ER<jats:sup>+<\/jats:sup> BrCa cells. Finally, knockdown or inhibition of Ezrin could restore the sensitivity of endocrine-resistant cells to antiestrogens treatment by activating ER\u03b1 signaling. Taken together, our findings unraveled a novel HAS2-Ezrin-ER route in regulating the sensitivity of ER<jats:sup>+<\/jats:sup> BrCa cells to antiestrogens, in which Ezrin may be a potential target in endocrine therapy.<\/jats:p>","DOI":"10.3389\/fphar.2022.1031487","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T04:27:44Z","timestamp":1667190464000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["HAS2-Ezrin-ER axis plays a role in acquired antiestrogen resistance of ER-positive breast cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaodan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1210\/en.2011-1950","article-title":"Dynamic changes in cervical glycosaminoglycan composition during normal pregnancy and preterm birth","volume":"153","author":"Akgul","year":"2012","journal-title":"Endocrinology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12282-017-0812-x","article-title":"Mechanism of resistance to endocrine therapy in breast cancer: The important role of PI3K\/Akt\/mTOR in estrogen receptor-positive, HER2-negative breast cancer","volume":"25","author":"Araki","year":"2018","journal-title":"Breast Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10549-013-2804-7","article-title":"Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival","volume":"143","author":"Auvinen","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"B4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1172\/jci10272","article-title":"Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme","volume":"106","author":"Camenisch","year":"2000","journal-title":"J. Clin. Invest."},{"key":"B5","doi-asserted-by":"publisher","first-page":"26038","DOI":"10.1074\/jbc.M114.564120","article-title":"Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor \u03b2 (TGF-\u03b2)-Snail signaling axis","volume":"289","author":"Chanmee","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1073\/pnas.0407113102","article-title":"Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1","volume":"102","author":"Cheung","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"11437","DOI":"10.1073\/pnas.1819155116","article-title":"Estrogen receptor signaling is reprogrammed during breast tumorigenesis","volume":"116","author":"Chi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1242\/jcs.133108","article-title":"ERM proteins in cancer progression","volume":"127","author":"Clucas","year":"2014","journal-title":"J. Cell Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"E53","DOI":"10.3390\/biom7030053","article-title":"MYC-driven pathways in breast cancer subtypes","volume":"7","author":"Fallah","year":"2017","journal-title":"Biomolecules"},{"key":"B10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast cancer","volume":"37","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrclinonc.2015.99","article-title":"Challenges in the management of advanced, ER-positive, HER2-negative breast cancer","volume":"12","author":"Hart","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/b978-0-12-800092-2.00008-3","article-title":"HAS2 and CD44 in breast tumorigenesis","volume":"123","author":"Heldin","year":"2014","journal-title":"Adv. Cancer Res."},{"key":"B13","first-page":"3331","article-title":"Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer","volume":"55","author":"Johnston","year":"1995","journal-title":"Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1111\/j.1742-4658.2010.07809.x","article-title":"The role of prohibitin in cell signaling","volume":"277","author":"Mishra","year":"2010","journal-title":"Febs J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.breast.2015.07.015","article-title":"The changing role of ER in endocrine resistance","volume":"24","author":"Nardone","year":"2015","journal-title":"Breast"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e904","DOI":"10.1038\/cddis.2013.439","article-title":"Nuclear NHERF1 expression as a prognostic marker in breast cancer","volume":"4","author":"Paradiso","year":"2013","journal-title":"Cell Death Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/sj.jid.5701098","article-title":"All-trans retinoic acid-induced hyaluronan production and hyperplasia are partly mediated by EGFR signaling in epidermal keratinocytes","volume":"128","author":"Pasonen-Sepp\u00e4nen","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/febs.14847","article-title":"Dissecting the role of hyaluronan synthases in the tumor microenvironment","volume":"286","author":"Passi","year":"2019","journal-title":"FEBS J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1042\/bcj20180054","article-title":"Extracellular ATP activates hyaluronan synthase 2 (HAS2) in epidermal keratinocytes via P2Y(2), Ca(2+) signaling, and MAPK pathways","volume":"475","author":"Rauhala","year":"2018","journal-title":"Biochem. J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"14636","DOI":"10.1074\/jbc.M500206200","article-title":"The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene","volume":"280","author":"Saavalainen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neo.2016.01.002","article-title":"Ezrin enhances EGFR signaling and modulates erlotinib sensitivity in non-small cell lung cancer cells","volume":"18","author":"Saygide\u011fer-Kont","year":"2016","journal-title":"Neoplasia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2004.04.024","article-title":"Estradiol-induced ezrin overexpression in ovarian cancer: A new signaling domain for estrogen","volume":"220","author":"Song","year":"2005","journal-title":"Cancer Lett."},{"key":"B23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0002-9440(10)63944-2","article-title":"NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas","volume":"158","author":"Stemmer-Rachamimov","year":"2001","journal-title":"Am. J. Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1210\/me.2010-0260","article-title":"Estrogen promotes the development of mouse cumulus cells in coordination with oocyte-derived GDF9 and BMP15","volume":"24","author":"Sugiura","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/01.res.0000119169.87429.a0","article-title":"Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins","volume":"94","author":"Sussmann","year":"2004","journal-title":"Circ. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/j.1742-4658.2011.08070.x","article-title":"Transcriptional and post-translational regulation of hyaluronan synthesis","volume":"278","author":"Tammi","year":"2011","journal-title":"Febs J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1038\/onc.2014.351","article-title":"A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells","volume":"34","author":"Thrane","year":"2015","journal-title":"Oncogene"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1126\/science.aah6893","article-title":"PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D","volume":"355","author":"Toska","year":"2017","journal-title":"Sci. (New York, N.Y.)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mce.2017.01.046","article-title":"Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells","volume":"444","author":"Vanneste","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/B978-0-12-800092-2.00004-6","article-title":"Hyaluronan synthases posttranslational regulation in cancer","volume":"123","author":"Vigetti","year":"2014","journal-title":"Adv. Cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"22945","DOI":"10.1074\/jbc.271.38.22945","article-title":"Molecular identification of a putative human hyaluronan synthase","volume":"271","author":"Watanabe","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"831507","DOI":"10.3389\/fonc.2022.831507","article-title":"Expression patterns of ezrin and AJAP1 and clinical significance in breast cancer","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1016\/j.biomaterials.2013.05.036","article-title":"The use of HA oligosaccharide-loaded nanoparticles to breach the endogenous hyaluronan glycocalyx for breast cancer therapy","volume":"34","author":"Yang","year":"2013","journal-title":"Biomaterials"},{"key":"B34","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41419-020-03037-0","article-title":"CD44\/HA signaling mediates acquired resistance to a PI3K\u03b1 inhibitor","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1172154","DOI":"10.1080\/2162402x.2016.1172154","article-title":"A novel role of breast cancer-derived hyaluronan on inducement of M2-like tumor-associated macrophages formation","volume":"5","author":"Zhang","year":"2016","journal-title":"Oncoimmunology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1042\/0264-6021:3490091","article-title":"Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: A molecular mechanism contributing to organ atrophy","volume":"349","author":"Zhang","year":"2000","journal-title":"Biochem. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/bcr2883","article-title":"Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK\/ERK and PI3K\/Akt signaling routes","volume":"13","author":"Zhang","year":"2011","journal-title":"Breast Cancer Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s41467-018-03951-0","article-title":"Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1031487\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T04:27:48Z","timestamp":1667190468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1031487\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":38,"alternative-id":["10.3389\/fphar.2022.1031487"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1031487","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"article-number":"1031487"}}